Press Releases
SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- BioPharma APAC recently published its Top 26 - Companies Leading Sustainable Biopharma Practices in 2026, highlighting leading sustainability practices across pharmaceutical companies, biotechnology firms and CRDMOs in Europe, North America and Asia Pacific, with a focus on Science Based Targets initiative (SBTi) commitments, value-chain decarbonization, green manufacturing, and sustainable operations. The list brings together... (continue reading...)
Monumental to Hold 60% Majority Stake
VANCOUVER, British Columbia--(BUSINESS WIRE)-- Monumental Energy Corp. (“*Monumental” or the “Company”) (TSXV: MNRG; FSE: ZA6; OTCQB: MNMRF) is pleased to announce that its application for petroleum exploration permit PEP61554, covering the Tirua Point application area in New Zealand’s Taranaki Basin, has been accepted by New Zealand Petroleum & Minerals (“NZPA”) and will now proceed to government review.
This press release... (continue reading...)
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly
Smith+Nephew (LSE:SN, NYSE: SNN), the global medical technology company, and Imperial College London have launched a five-year partnership to deliver breakthrough research and innovation for robotic surgery for musculoskeletal conditions.
The first-in-kind partnership will bring together a globally... (continue reading...)
BALLERUP, Denmark--(BUSINESS WIRE)-- In H1 2026, LEO Pharma delivered strong revenue growth, driven by the dermatology portfolio, with an improved gross margin alongside significantly increased investments in commercial and innovation activities. In August, LEO Pharma agreed to acquire the global rights for dersimelagon, an investigational first-in-class oral therapy with potential launch in 2027. Together with the acquisition of Replay, announced in April 2026, the... (continue reading...)
ANS-858 is being developed to reduce pathological craving associated with alcohol and other substance use disorders.
Amygdala's ALDH2 inhibitor platform offers additional therapeutic opportunities in binge eating, obesity, and precision oncology.
PALO ALTO, Calif., Aug. 18, 2026 /PRNewswire/ -- Amygdala Neurosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for ANS-858,... (continue reading...)
More Press Releases
View Older Stories-
Grupo Boticário and Haut.AI Expand Strategic Partnership to Nearly 4,000 O Boticário Stores
-
Overcoming the Affordable Housing Deficit: Housing New Mexico Featured on "All Access hosted by Andy Garcia"
-
Can Independent Critical Access Hospitals Solve the Rural Healthcare Crisis? "All Access hosted by Andy Garcia" Features Syracuse Area Health
-
Queue-it Announces Majority Investment from THL Partners
-
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma
-
Aitech Announces New U-C6850 SOSA-Aligned Rugged High-Speed Ethernet Switch/Router for Defense and Aerospace Systems
-
Beno Opens Luxury Waterfront Guest Lounge at Marsa Al Arab in Partnership with Jumeirah Group
-
Keep Your Cool When the Vibes Heat Up: Desperados and Paolina Russo Drop the Ultimate Festival Jacket Powered by Frozen Beer
-
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
-
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
-
LEO Pharma Further Strengthens Late-Stage Pipeline With the Acquisition of Dersimelagon
-
CesiumAstro Acquires Jariet Technologies to Advance Vertically Integrated Communications and ISR from Silicon to Missions
-
Announcement pursuant to section 23(1) sentence 1 no. 3 of the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz - WpÜG)
-
PrimeS4 Earns SAP Supply Chain Expert Competency, Expanding Enterprise Transformation Capabilities
-
New Crypto Presale Pepeto Reveals Funds Update While Ethereum Price Prediction Targets $10,000
-
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
-
Provable Opens Early Access to Shield Swap, a Confidential Trading Venue Built for Compliance
-
Syncron Wins Bronze Stevie® Award in 2026 International Business Awards®
-
TotalEnergies SE: Disclosure of Transactions in Own Shares
-
$2M Raised By BlockDAG in a Day: How Do BNB at $605 and Solana at $76 Compare?
-
Ondo Brings 260+ Stocks to Hyperliquid as AlphaPepe Turns AI Trading Into a Pre-Launch Meme Coin Opportunity
-
BlockDAG Soars With Over $2M Raised in 24 Hours, Securing Its Place as a Top Crypto to Buy in 2026
-
Best Crypto To Buy Now: Every AlphaSwap Trade Can Burn ALPE as This Crypto Presale Builds Scarcity Into Real Usage
-
Dogecoin & Shiba Inu Stagnate, While BlockDAG Draws $2M in a Single-Day Presale Surge
-
Bitcoin Price Prediction: Six Failed $65K Breakouts Frustrate Bulls as AlphaPepe Gives Retail a Smaller-Cap Trade Before Exchange Pricing
-
Crypto Investors Are Looking Past Market Caps, 6 Best Crypto Presales Built Around Utility, Not Just Hype
-
Ethereum Price Prediction: Retail Dumps 160K ETH as Whales Load Up for $2K, This AI Presale Hunts the Bigger 100x Setup
-
Tempest Droneworx Unveils Game-Changing Corvus MRDR™ for Developers
-
NEXTDC Receives Frost & Sullivan's 2026 Australia Competitive Strategy Leadership Recognition for Excellence in Data Center Services Innovation and Growth
-
Blockchain.com Admitted to Nigeria SEC's Accelerated Regulatory Incubation Programme
-
XCMG Co-organizes 15th China Innovation & Entrepreneurship Competition "AI + Construction Machinery" Division as Registration Opens
-
Kailas FUGA Continues Trail Shoe Innovation with New FUGA EX PRO G
-
Synthesized Introduces Test Data Agent, Bringing Production-Faithful Validation to Enterprise AI Agents
-
Equinor ASA: Share buy-back – third tranche for 2026
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
TRAFiX supports Sigma Capital Partners MENA Limited’s international expansion
-
Holding(s) in Company
-
Progress on share buyback programme
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 18
-
Best ZAMAC Cap and Candle Lid Manufacturers for Luxury Fragrance Packaging: 5 Supplier Profiles Reviewed
-
Vantage Expands Pre-IPO CFD Offering with Unitree Robotics as Interest in Frontier AI Grows
-
Virtualware signs agreement to acquire British company Virtalis
-
Five One Eight Contracting Wins 2026 IABE National Excellence Award
-
Coloplast A/S - Interim Financial Report, 9M 2025/26
-
Multiconsult second quarter and first half 2026 - Improved reported profitability and good order intake
-
Braskem Idesa, S.A.P.I takes strategic action through consensual restructuring to reduce its debt by more than US$920 MM
-
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
-
Ingenia Therapeutics Goes Public on KOSDAQ to Accelerate Pipeline of Next-Generation Vascular Antibody Therapeutics
-
Start of Day Message
